Cypress Asset Management Inc Biogen Inc. Transaction History

Cypress Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 29, 2019	SELL	$216.71 - $338.96 $171,200 - $267,778	-790 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $6,962 - $8,818	-25 Reduced 3.07%	790 $238,000
Q2 2018 Jul 27, 2018	SELL	$257.52 - $306.91 $84,981 - $101,280	-330 Reduced 28.82%	815 $237,000
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $72,836 - $103,014	-280 Reduced 19.65%	1,145 $314,000
Q4 2017 Jan 31, 2018	SELL	$307.64 - $344.58 $86,754 - $97,171	-282 Reduced 16.52%	1,425 $454,000
Q3 2017 Nov 08, 2017	BUY	$281.15 - $329.69 $479,923 - $562,780	1,707	1,707 $534,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Cypress Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cypress Asset Management Inc with notifications on news.